#cell therapy — RxWyre

Illustration of engineered T cells with surface receptors attacking a target cell

Health

CAR-T Therapy Explained: How It Works, What It Treats, and Its New Role in Autoimmune Disease

CAR-T turns a patient’s own immune cells into a living drug. It has transformed some blood cancers and is now being tested in lupus and multiple sclerosis. A plain-language guide to the process, the risks and what comes next.

Oct 2, 2026 · 4 min read

Illustration of an mRNA strand inside a lipid nanoparticle with immune cells nearby

Business

Novartis Bets Up to $7.8 Billion on an mRNA Drug That Turns the Body Into Its Own Antibody Factory

The Swiss drugmaker is paying China’s Abogen $575 million upfront for an injected mRNA that makes a B-cell-killing T-cell engager inside the patient — a possible simpler route to the “immune reset” that CAR-T promised for autoimmune disease.

Oct 2, 2026 · 4 min read

Conceptual illustration of an AI foundation model designing proteins and cell therapies from a gene atlas

Business

Anthropic- and Nvidia-Backed Startup Raises $140M to Let AI Design Living Medicines

Basecamp Research trained a biological “foundation model” on the world’s largest proprietary gene dataset — and wants to use it to design therapies that reprogram a patient’s own cells inside the body.

Sep 23, 2026 · 2 min read